Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up
Figure 4
(a). Evolution of creatinine clearance over time in the randomization population (MMF group versus control group). (b) Evolution of creatinine clearance over time in the on-treatment population (group I versus group II). The vertical, dotted line separates initial study phase and follow up phase.
